Guy Young

65PUBLICATIONS
121CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (65)

|Jul 24, 2026
T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers.

|Jul 17, 2026
Denecimig (Mim8) prophylaxis once-every-2-weeks for hemophilia A with or without inhibitors - 26-week results from FRONTIER.

|Jun 24, 2026
Concizumab in patients with hemophilia A or B without inhibitors: 56-week cut-off results of the phase 3 explorer8 study.

|Jun 08, 2026
Advances in Hemophilia: From Joint Health to FVIII Guidelines and the Clinical Integration of Rebalancing Agents.

|Apr 16, 2026
New Treatment in Haemophilia: Challenges, Controversies and Uncertainties.

|Feb 26, 2026
From nothing to abundance for hemophilia with inhibitors.

Guy Young

Pageof 11

Frequent Collaborators

9 joint publications

Johnny N Mahlangu

8 joint publications

Steven W Pipe

7 joint publications

Flora Peyvandi

6 joint publications

Víctor Jiménez-Yuste